´ëÇѺñ´¢ÀÇÇÐȸ È£³²Áöȸ Áý´ãȸ : 2021-12-10±³À°ÀÏÀÚ : 2021-12-10
±³À°Àå¼Ò : ´õ ¸ÞÀÌ È£ÅÚ 1Ãþ ¸ÞÀ̺§Áî
±³À°ÁÖÁ¦ :
´ëÇѺñ´¢ÀÇÇÐȸ È£³²Áöȸ Áý´ãȸÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : È£³²Áöȸ
´ã´çÀÚ : À̼¼Èñ
¿¬¶ôó : 02-573-8190
À̸ÞÀÏ :
urology@urology.or.kr ±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª :
Àü¶óºÏµµ±³À°½Ã°£ : 2 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í 1. ¼±Âø¼ø 50ÀÎ ÀÌÇÏ Á¢¼ö (»çÀüµî·Ï¸¸ °¡´É) 2. ÇöÀåµî·Ï ¾ø½À´Ï´Ù.
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12-10 ÀüÁÖ ´õ ¸ÞÀÌ È£ÅÚ, 1Ãþ ¸ÞÀ̺§Áî 15:30~16:00 Current challenges in analyzing gut microbiome È«¼ºÃâ(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 12-10 ÀüÁÖ ´õ ¸ÞÀÌ È£ÅÚ, 1Ãþ ¸ÞÀ̺§Áî 16:00~16:15 Treatment of the Primary Tumor in mHSPC ¹Ú½Âö(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 12-10 ÀüÁÖ ´õ ¸ÞÀÌ È£ÅÚ, 1Ãþ ¸ÞÀ̺§Áî 16:15~16:30 Treatment options for mHSPC in clinical practice À¯¼ºÇö(Àü³²ÀÇ´ë)
±³À°½Ã°£ 12-10 ÀüÁÖ ´õ ¸ÞÀÌ È£ÅÚ, 1Ãþ ¸ÞÀ̺§Áî 16:30~16:45 Definition and Treatment options of nmCRPC in clinical practice ±è¸í±â(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 12-10 ÀüÁÖ ´õ ¸ÞÀÌ È£ÅÚ, 1Ãþ ¸ÞÀ̺§Áî 16:45~17:00 Sexual function in men with advanced prostate cancer Àº¼ºÁ¾(Àü³²ÀÇ´ë)
ÈÞ½Ä 12-10 ÀüÁÖ ´õ ¸ÞÀÌ È£ÅÚ, 1Ãþ ¸ÞÀ̺§Áî 17:00~17:20 Coffee break ¹× »çÁøÃÔ¿µ ()
±³À°½Ã°£ 12-10 ÀüÁÖ ´õ ¸ÞÀÌ È£ÅÚ, 1Ãþ ¸ÞÀ̺§Áî 17:20~17:50 Ư° Urolift – Who & When ? ±èÅÂÈ¿(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 12-10 ÀüÁÖ ´õ ¸ÞÀÌ È£ÅÚ, 1Ãþ ¸ÞÀ̺§Áî 17:50~18:10 Desmoid type fibromatosis Á¶ÇöÁø(Àü³²ÀÇ´ë)
±âŸ 12-10 ÀüÁÖ ´õ ¸ÞÀÌ È£ÅÚ, 1Ãþ ¸ÞÀ̺§Áî 18:10~18:20 °øÁö ¹× ÃÑȸ ()